Key terms

About ACCD

Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company was founded by Thomas K. Spann, J. Michael Cline, and Sudhir Steven Singh in January 2007 and is headquartered in Seattle, WA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ACCD news

Today 8:05am ET Analysts Are Bullish on These Healthcare Stocks: Accolade (ACCD), PROCEPT BioRobotics (PRCT) Today 7:29am ET Truist Financial Sticks to Its Buy Rating for Accolade (ACCD) Today 6:11am ET Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD) Today 6:08am ET Accolade’s Hold Rating Affirmed Amid Conservative Outlook and Adjusted Financial Estimates Today 5:45am ET Accolade’s Hold Rating Affirmed Amid Revenue Growth Uncertainty and Earnings Volatility Today 4:48am ET Barclays Remains a Hold on Accolade (ACCD) Apr 22 6:33am ET Accolade price target lowered to $13 from $15 at Stifel Apr 22 1:31am ET Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG) Apr 18 6:10am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY) Mar 19 9:04am ET Accolade promotes Kelsi McDonald Harris to Chief People Officer Feb 27 5:59am ET Balancing Potential and Prudence: A Hold Rating for Accolade’s Market Prospects and Financial Strategy Feb 26 8:25am ET D.A. Davidson Remains a Hold on Accolade (ACCD) Feb 26 6:44am ET Accolade initiated with an Outperform at Leerink Feb 06 7:48am ET Stifel Nicolaus Sticks to Their Buy Rating for Accolade (ACCD)

No recent press releases are available for ACCD

ACCD Financials

1-year income & revenue

Key terms

ACCD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ACCD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms